Akso Health Group

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($13.1m) ($9.1m) ($135.5m) ($18.7m)
Net Income (Loss) Attributable to Parent $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Net Income (Loss) Available to Common Stockholders, Basic $65.5m $5.5m ($71.2m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Net loss from continuing operations ($4.3m) ($4.1m) ($13.1m) ($9.1m) ($135.5m)
Loss from disposal of discontinued operations ($3.2m) $396k
Less: cash and cash equivalents of discontinued operations at end of period $13.6m $3.5m $1.3m $1.0m
Cash and cash equivalents of continuing operations, at end of period $19.2m $132.6m $18.4m $7.9m $85.2m $176.2m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $65.5m $5.5m ($71.2m) ($16.8m) ($1.2m) ($9.5m) ($135.5m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($16.9m) ($13.1m) ($9.1m) ($135.5m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($31.6m) ($16.8m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $11.8m ($400k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($3.3m) $11.8m
Net Income (Loss) Attributable to Noncontrolling Interest $29k $1k $112k ($58k) ($492k)
Depreciation, Depletion and Amortization $92k $174k $407k $581k $15k $18k $0 $0 $2.1m
Amortization of Intangible Assets $2.1m
Depreciation $92k $174k $407k $581k $15k $18k $0 $0 $2k
Depreciation Amortization Depletion $0 $0 $2.1m $2.4m
Deferred Income Tax Expense (Benefit) $416k ($3.7m) $3.6m ($30.8m)
Deferred tax (benefit) expense $136k $416k ($30.8m)
Deferred Income Tax $0 $0 ($30.8m) ($2.0m)
Deferred Tax $0 $0 ($30.8m) ($2.0m)
Share-based Payment Arrangement, Noncash Expense $1.8m $6.6m $347k $55k $392k
Share-based Payment Arrangement, Expense $1.8m $6.6m $347k $55k $392k
Goodwill and Intangible Asset Impairment $162.4m
Goodwill, Impairment Loss $41.4m
Impairment of Intangible Assets (Excluding Goodwill) $121.1m
Asset Impairment Charge $0 $0 $162.5m $16.7m
Gain (Loss) on Disposition of Property Plant Equipment ($288k) ($456k) ($5k) ($29k) ($17k) ($5k) ($154k)
Income Tax Expense (Benefit) $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m)
Operating Lease, Expense $2.0m $399k $467k $11k
Other Nonoperating Income (Expense) $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k)
Operating lease liabilities $754k ($787k) $82k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories $7.8m ($6.1m) ($1.5m)
Foreign Currency Transaction Gain (Loss), before Tax ($592k) ($26)
Gain (Loss) on Termination of Lease $0
General and Administrative Expense $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m
Goodwill $10.8m
Nonoperating Income (Expense) $34k
Operating Expenses $31.4m $16.9m $15.5m $8.8m $166.0m
Proceeds from Contributed Capital $124k
Proceeds from Stock Options Exercised $1.2m $282k $5
Revenue from Contract with Customer, Including Assessed Tax $82.6m $19.0m $6.3m $13.2m
(Recovery of) Provision for doubtful accounts $1.1m $16.1m $8.3m $7.4m ($100k)
Accounts receivable ($8.1m) $327k ($860k)
Prepayments and other assets ($2.5m) $3.1m ($2.2m) $899k ($113k) ($507k) ($95k) ($131k) ($6.4m)
Inventories ($7.8m) $6.1m $1.5m
Accounts payable, accrued expenses and other current liabilities ($2.6m) $2.5m ($469k) ($338k) ($82k) ($104k) $713k $166k $417k
Contract liabilities $301k ($65k) $194k $221k $9.9m
Taxes payable $2.2m $14.7m ($9.4m) ($2.6m) $337k ($184k) $3k ($22k) ($41k)
Cash paid for loan originations ($34.7m) ($123.5m) ($6.1m) ($20.0m) ($1.5m) ($35.5m)
Cah paid in connection with acquisition ($56.2m) ($93.8m)
Cash received from loan repayments $7.5m $72.9m $33.8m $407k $41k $20.0m $1.5m $23.5m
Repayments of loans due to related parties ($5.9m) ($27.5m) ($7.7m)
Proceeds from private placement, net of offering costs $2.0m $10.0m $139.3m $195.9m
Beginning Cash Position $21.9m $9.2m $86.2m $176.2m
Cash Flow From Continuing Financing Activities ($27.5m) $131.7m $195.9m $350k
Cash Flow From Continuing Investing Activities $18.5m ($54.7m) ($105.9m) ($163.5m)
Cash From Discontinued Financing Activities $0 $0 $0 $0
Cash From Discontinued Investing Activities $0 $0 $0 $0
Change In Account Payable $713k $166k $417k $313k
Change In Accrued Expense $0 $0 $0 $527
Change In Income Tax Payable $3k ($22k) ($41k) $59k
Change In Interest Payable $0 $0 $0 $527
Change In Inventory $6.1m $1.5m $0 $0
Change In Other Current Liabilities $0 $0 $82k ($57k)
Change In Other Working Capital $194k $221k $9.9m ($5.8m)
Change In Payable $716k $144k $377k $372k
Change In Payables And Accrued Expense $716k $144k $377k $373k
Change In Prepaid Assets ($95k) ($131k) ($6.4m) ($5.4m)
Change In Receivables ($8.1m) $327k ($860k) ($435k)
Change In Tax Payable $3k ($22k) ($41k) $59k
Change In Working Capital ($1.2m) $2.1m $3.0m ($11.3m)
Changes In Account Receivables ($8.1m) $327k ($860k) ($435k)
Changes In Cash ($12.3m) $78.3m $91.1m ($175.9m)
End Cash Position $9.2m $86.2m $176.2m $171k
Financing Cash Flow ($27.5m) $131.7m $195.9m $350k
Free Cash Flow ($3.3m) $1.4m $1.0m ($188.5m)
Investing Cash Flow $18.5m ($54.7m) ($105.9m) ($163.5m)
Issuance Of Capital Stock $0 $139.3m $195.9m $0
Net Business Purchase And Sale $0 ($56.2m) ($93.8m) $0
Net Intangibles Purchase And Sale $0 $0 ($175.7m)
Net PPE Purchase And Sale $0 $0 ($154k) ($2k)
Other Non Cash Items $396k ($99k) $84k
Proceeds From Stock Option Exercised $0 $0
Provisionand Write Offof Assets $8.3m $7.4m ($100k) $109k
Purchase Of Business $0 ($56.2m) ($93.8m) $0
Purchase Of Intangibles $0 $0 ($175.7m)
Purchase Of PPE $456k $945k $315k $200k $5k $0 $0 ($154k) ($2k)
Stock Based Compensation $392k $0 $0
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax $3.2m ($396k)
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($6.4m) $11.8m ($4k)
Net Cash Provided by (Used in) Operating Activities $8.2m $87.7m ($1.7m) ($55.9m) $10.1m ($8.6m) ($3.3m) $1.4m $1.2m ($12.8m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($5k) $154k ($175.7m)
Payments to Acquire Businesses, Net of Cash Acquired $93.8m
Net Other Investing Changes $18.5m $1.5m ($12.0m) $12.2m
Net cash (used in)provided by investing activities from continuing operations ($67.1m) $17.4m $407k ($20.0m) $18.5m ($54.7m) ($105.9m)
Net cash provided by investing activities from discontinued operations ($1.0m) ($4.6m) ($408k) $36k
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES ($288k) ($27.6m) ($68.1m) $12.8m ($662) ($20.0m) $18.5m ($54.7m) ($105.9m)
Net Cash Provided by (Used in) Investing Activities ($27.6m) ($68.1m) $12.8m ($662) ($20.0m) $18.5m ($54.7m) ($105.9m)
Cash flows from financing activities:
Issuance Of Debt $0 $0 $350k
Net Issuance Payments Of Debt ($27.5m) ($7.7m) $0 $350k
Net Short Term Debt Issuance ($27.5m) ($7.7m) $0 $350k
Short Term Debt Issuance $0 $0 $350k
Repayment Of Debt ($27.5m) ($7.7m) $0 $0
Short Term Debt Payments ($27.5m) ($7.7m) $0 $0
Common Stock Issuance $0 $139.3m $195.9m $0
Net Common Stock Issuance $0 $139.3m $195.9m $0
Payments for Repurchase of Common Stock $1.3m $2.7m
Payments of Ordinary Dividends, Common Stock $20
Proceeds from Noncontrolling Interests $4.5m
Net cash provided by (used in) financing activities from continuing operations $51.4m ($8.2m) ($9.1m) $34.8m ($27.5m) $131.7m $195.9m
Net cash provided by financing activities from discontinued operations ($51.4m) $6.7m $37k $25.7m
Net Cash Provided by (Used in) Financing Activities $4.3m $47.5m ($29k) ($4.0m) ($9.0m) $34.8m ($27.5m) $131.7m $195.9m
EFFECT OF EXCHANGE RATE CHANGE ON CASH ($777k) $5.8m ($5.4m) $609k $3.2m $608k ($437k) ($1.3m) ($1.1m)
Effect Of Exchange Rate Changes ($437k) ($1.3m) ($1.1m) ($153k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($75.3m) ($46.4m) $4.2m $6.8m ($12.7m) $77.0m $90.0m
NET INCREASE (DECREASE) IN CASH $11.4m $113.4m ($75.3m) ($46.4m) $4.2m $6.8m ($12.7m) $77.0m $90.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57.4m $10.9m $21.9m $9.2m $86.2m $176.2m
CASH AND CASH EQUIVALENTS – beginning of year $19.2m $132.6m $57.4m $10.9m $15.1m $21.9m $9.2m $86.2m $176.2m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($12.7m) $77.0m $90.0m ($176.1m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.4m $2.1m $677k $337k $112k
Income Taxes Paid, Net $301k $1.0m $12.2m $3.2m $10k $39k $337k $25k $3k $2k